Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Developed dermatographia 2 weeks later; This spontaneous case was reported by a patient and describes the occurrence of MECHANICAL URTICARIA (Developed dermatographia 2 weeks later) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On 30-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. On 14-Nov-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MECHANICAL URTICARIA (Developed dermatographia 2 weeks later). At the time of the report, MECHANICAL URTICARIA (Developed dermatographia 2 weeks later) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use), the reporter did not provide any causality assessments. The patient had no risk factor. No concomitant medication was reported. It was reported that post Moderna Covid booster vaccination patient was developed symptom of dermatographia 2 weeks later. She was experienced whole body intense itchy, and patent was reported that when she scratches the red marks appeared and then disappeared approximately 30 minutes later. It was reported that the patient can write words on the skin that used to disappear. This symptom was lasted for about 1.5-2 years for patient. It had gotten better over time for patient but still the symptom showed the red marks when she scratched the skin. The patient did not experience any additional symptoms/events. There were no lab data/results available. No treatment medication was reported. Reporter causality was not reported.